Cargando…
Mitochondrial dysfunction and Alzheimer’s disease: prospects for therapeutic intervention
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disease and has become a major socioeconomic issue in many developed countries. Currently available therapeutic agents for AD provide only symptomatic treatments, mainly because the complete mechanism of the AD pathogenesis is still uncl...
Autores principales: | Lim, Ji Woong, Lee, Jiyoun, Pae, Ae Nim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999825/ https://www.ncbi.nlm.nih.gov/pubmed/31818365 http://dx.doi.org/10.5483/BMBRep.2020.53.1.279 |
Ejemplares similares
-
Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer’s disease
por: Yoo, Seung-Min, et al.
Publicado: (2020) -
The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease
por: Kim, Dong Kyu, et al.
Publicado: (2019) -
Mitochondrial transplantation: an overview of a promising therapeutic approach
por: Kim, Ji Soo, et al.
Publicado: (2023) -
Therapeutic applications of gene editing in chronic liver diseases: an update
por: Shin, Ji Hyun, et al.
Publicado: (2022) -
Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease
por: Onyango, Isaac G.
Publicado: (2018)